#52 TrialNet with Dr. Carla Greenbaum

TrialNet is a collaborative effort to prevent type 1 diabetes...

Learn more about TrialNet with Dr. Carla Greenbaum - TrialNet is an international network of centers dedicated to the study, prevention and early treatment of type 1 diabetes. We have clinical centers in the United States, Canada, Europe and Australia.

Learn more about TrialNet today!

The worlds only tubeless insulin pump by clicking here, try a free demo today.

---

#49 Bigfoot Biomedical CEO talks about their artificial pancreas

The story of a closed loop artificial pancreas company and where it hopes to go...

View fullsize

Bigfoot Biomedical is a company dedicated to the development of a closed loop insulin delivery system. Founded and run by the parents and loved ones of people living with type 1 diabetes, Bigfoot has a personal investment in getting to market as soon as possible. Episode 49 is with Jeffrey Brewer, former CEO of the JDRF and current CEO of Bigfoot. The future isn't so far away.

Show Notes

Learn more about Bigfoot at their blog.

Subscribe to the podcast on iTunes today!

The OmniPod insulin delivery system is the worlds only tubeless insulin pump, click to find out more.

---

#48 Aaron Kowalski, JDRF Chief Mission Officer

Aaron Kowalski is the Chief Mission Officer for the JDRF, a PWD and by all accounts a really good guy.

View fullsize

In this episode of the podcast Aaron and I kick back and talk about type 1 diabetes, the directions that the JDRF is taking and a bunch more.

Dr. Kowalski oversees JDRF-funded research aimed at accelerating the delivery of therapies that will help keep people healthy while living with diabetes and minimize their risk for developing diabetes complications, as well as treatments that will help those who have developed diabetic complications. Dr. Kowalski is an internationally recognized expert in the area of diabetes technologies and has been a leader since its inception in 2005 of the JDRF Artificial Pancreas Project, a multimillion-dollar initiative aimed at accelerating progress towards a closed-loop automated insulin-delivery system and diabetes technologies that will improve blood sugar control in people with diabetes. He has published numerous articles in the field, including co-authoring the landmark New England Journal of Medicine publication demonstrating the effectiveness of continuous glucose monitors in type 1 diabetes.

Subscribe & listen to the Juicebox Podcast on iTunes > SUBSCRIBE

---